Thyroid cancer associated with MEN types 2A and 2B
Medullary
First lab test for thyroid nodule
TSH level
Electrolyte abnormality following thyroid surgery
Hypocalcemia (from parathyroid injury)
Diagnosis of annular scaly patch with central clearing
Tinea infection
Topical treatment for impetigo
Mupirocin or retapamulin
Treatment of nonthyroidal illness syndrome
Observation
Most common cause of non–PTH-mediated hypercalcemia
Malignancy
T1DM antibody testing in new diagnosis
Glutamic acid decarboxylase (GAD)
Pigmented macule with a surrounding hypopigmentation
Halo nevus
Cause of linearly arranged pruritic papules found in the morning
Bed bug bites
Treatment of men with biochemically proven hypogonadism
Testosterone therapy
Main two options for blood glucose monitoring (BGM)
Fingerstick BGM and continuous glucose monitoring (CGM)
Drugs for diabetic peripheral neuropathy
Gabapentinoids, SNRIs, tricyclic antidepressants, sodium channel blockers
Pearly or translucent nodule or papule with arborizing telangiectasias, often with central depression with rolled waxy border
Nodular basal cell carcinoma
Three-color targetoid lesions on face and acral sites
Erythema multiforme
TSH level indication for subclinical hypothyroidism treatment
>10 µU/mL
Diagnosis of osteoporosis in postmenopausal women and men >50 years
T-score ≤−2.5 or fragility fracture (especially hip or vertebral compression fracture)
Bone indication for hyperparathyroidism-related parathyroidectomy
T-score ≤−2.5 or vertebral fracture
Highest-potency formulation among dermatologic ointments, solutions, and suspensions
Ointments
DIHS treatment
Discontinue causative drug, glucocorticoids
Most common cause of primary adrenal insufficiency (Addison disease)
Autoimmune adrenalitis
Prophylaxis for glucocorticoid-related osteoporosis
Bisphosphonate, denosumab
Drug class used before adrenalectomy for pheochromocytoma
α-Receptor blocker
Primary prognostic feature for melanoma
Depth of invasion (Breslow depth)
Hematologic conditions associated with Sweet syndrome
Myelodysplastic syndrome, AML